Resignation of Chief Marketing Officer

ADMIN
Mon, Aug 23 2021 09:30 am

23 August 2021

Resignation of Chief Marketing Officer

Blis Technologies wishes to advise that Chief Marketing Officer, Julie Curphey, has advised of her resignation from her role effective 29 October 2021.

Julie joined the company in September 2016 and has had an integral role in several new product and new market launches during that time.

CEO Brian Watson said: “I’d personally like to thank Julie for her contribution over the last 5 years and wish her well for her future endeavours. Julie has led a number of significant launch initiatives for the company, has increased our market presence as a brand and has helped broaden our revenue opportunities for the future.”

Julie is taking time off and will assess her future direction in the new year.

A search for Julie’s replacement will commence shortly.

Ends

For further information, please contact:

Brian Watson
CEO
+64 27 705 9133


About Blis Technologies Ltd

Delivering proven health benefits through evidence-based, advanced probiotics
Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS® products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz.

Website: www.unconditionalskin.com
Instagram: @unconditionalskin #BLISQ24 #USC
Facebook: @unconditionalskin


Announcement PDF


Markets News

Markets Market Close

NZ sharemarket rises strongly on power company gains

Positive day for Mercury and Meridian as well as a2 Milk despite gloom on global front. 

Tom Raynel 04 Jun 2025
NZ sharemarket rises strongly on power company gains
Markets

Inside Ebos’s ‘revolutionary’ $1.1 billion deal

In 2013, Ebos swallowed a giant. Now it’s the end of an era.

Inside Ebos’s ‘revolutionary’ $1.1 billion deal